Results 181 to 190 of about 74,736 (296)

Metabolic Reprogramming of the Pre‐Metastatic Niche: A Sweet Spot for Anti‐Tumor Immunity

open access: yes
MedComm – Oncology, Volume 5, Issue 1, March 2026.
Xuan Zhang, Xinghua Long
wiley   +1 more source

Impact of Add‐On Hepatobiliary Abbreviated Magnetic Resonance Imaging on Ultrasound Hepatoma Surveillance for Liver Cirrhosis‐ a Randomized Study

open access: yesThe Kaohsiung Journal of Medical Sciences, Volume 42, Issue 2, February 2026.
ABSTRACT Hepatocellular carcinoma (HCC) surveillance with semi‐annual ultrasound (US) is recommended for high‐risk patients. This study investigates the impact of hepatobiliary abbreviated magnetic resonance imaging (AMRI) performed annually on the recommended US surveillance.
Jing‐Houng Wang   +4 more
wiley   +1 more source

Pediatric Alpha-Fetoprotein-Producing Gastric Cancer Presenting With Dysphagia and Multiple Liver Tumors. [PDF]

open access: yesCancer Rep (Hoboken)
Hirano T   +10 more
europepmc   +1 more source

Radiogenomics: Current Understandings and Future Perspectives

open access: yesMedComm, Volume 7, Issue 2, February 2026.
Radiogenomics links imaging phenotypes with genetic variations, offering potential for comprehensive understanding, cost‐effective diagnosis, and prognosis prediction to advance personalized medicine. However, its clinical application remains limited by several challenges.
Xinyu Zhang   +8 more
wiley   +1 more source

Proteomic profiling of porcine seminal extracellular vesicles reveals potential in vivo fertility biomarkers

open access: yesAndrology, Volume 14, Issue 2, Page 555-570, February 2026.
Abstract Background Predicting male fertility in farm animals remains a challenge. Seminal plasma (SP) contains a high amount of heterogeneous seminal extracellular vesicles (sEVs), believed involved in reproductive processes and maybe key to understanding male fertility.
Isabel Barranco   +6 more
wiley   +1 more source

Research Communication: Serum Metabolomic Signatures Predict Tumour Recurrence After Resection or Ablation in Patients With Early‐Stage Hepatocellular Carcinoma

open access: yesAlimentary Pharmacology &Therapeutics, Volume 63, Issue 3, Page 414-418, February 2026.
Serum metabolites may guide post‐treatment risk stratification for HCC recurrence. ABSTRACT Patients with hepatocellular carcinoma (HCC) often experience recurrence after curative therapies, underscoring a need for risk stratification models. We validated 6 and 13‐metabolite signatures in patients who achieved complete response following surgical ...
Ashwini Arvind   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy